Business Context and Reporting Period
Company: ARGENX SE
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: January 2026 (Specifically January 13, 2026)
Context: This filing serves to incorporate by reference a press release issued on January 13, 2026 (Exhibit 99.1). The document confirms the company's status as a registrant filing under Form 20-F and incorporates the information into existing Registration Statements on Form S-8.
Key Financial Metrics
The provided filing text does not contain specific financial data. It is a procedural report referencing an external press release. Consequently, the following metrics are not available in this document:
- Revenue
- Profit
- Cash Flow
- Margins
- Debt
- Liquidity
Material Changes
The filing text does not provide details on material changes versus prior periods. It only indicates that a press release was issued on the filing date, the contents of which are not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumed to be within the attached Exhibit 99.1 (Press Release), which is not part of the input content.
Investor Verification Checklist
- Verify the full content of the Press Release dated January 13, 2026 (Exhibit 99.1), as the financial and operational details are located there.
- Confirm the specific nature of the announcement (e.g., clinical trial results, regulatory approval, or corporate action) referenced in the press release.
- Review the incorporated Registration Statements on Form S-8 (File Nos. 333-292200, 333-225375, 333-258253, and 333-274721) for updated terms if the press release impacts equity plans.